在树突细胞的免疫调节中介质干细胞:对于炎症性肠病治疗的含义
Dongqin Song1, Chang'e He2, Dickson Kofi Wiredu Ocansey3
1Key Laboratory of Medical Science and Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang 212013, China.
Autoimmunity reviews
|June 25, 2025
概括
介质干细胞 (MSC) 和它们的外体通过调节树突细胞 (DC) 来显示炎症性肠病 (IBD) 的治疗潜力. 对MSC机制的进一步研究对于推进IBD治疗至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 再生医学是一种再生医学.
背景情况:
- 炎症性肠病 (IBD) 是一种慢性自身免疫性疾病,导致肠道炎症,目前的治疗只能提供症状缓解.
- 介酶干细胞 (MSC) 具有免疫调节特性,表明IBD的治疗潜力,但它们的精确机制需要阐明.
- 树突细胞 (DCs) 是IBD免疫反应的关键参与者,但它们的特定作用和相互作用尚未完全理解.
研究的目的:
- 在炎症性肠病 (IBD) 的背景下,审查介质干细胞 (MSC) 和它们衍生的外体在调节树突细胞 (DC) 中的作用.
- 通过检查它们对DC功能和免疫调节的影响,探索MSCs对IBD的治疗潜力.
- 为MSCs影响IBD中DC活动的机制提供见解.
主要方法:
- 文献综述专注于研究MSCs,外体,树突细胞和炎症性肠病的研究.
- 对MSC及其外体对DC种群的免疫调节作用的当前研究进行分析.
- 综合与IBD中DC介导免疫反应相关的发现,以及MSC基础疗法的影响.
主要成果:
- MSC及其外体对树突细胞 (DC) 显示出显著的免疫调节作用.
- 由MSC衍生的外体可以改变DC成熟,抗原呈现和细胞因子产生,从而影响IBD中的免疫微环境.
- 有证据表明,MSCs和外体可以抑制IBD模型中DCs介导的促炎反应.
结论:
- 介质干细胞 (MSC) 和它们的外体细胞通过它们对树突细胞 (DC) 的调节,代表了炎症性肠病 (IBD) 的有前途的治疗策略.
- 以MSC为基础的疗法准DC功能为管理IBD提供了一种新的方法.
- 对MSC-DC相互作用背后的特定分子机制进行进一步的研究是有必要的,以优化IBD的治疗应用.
相关概念视频
Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
278
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
278
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.2K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
Renewal of Intestinal Stem Cells
2.7K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.7K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K


